𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials

✍ Scribed by F. Fabrizi; S. V. Ganeshan; G. Lunghi; P. Messa; P. Martin


Book ID
108886145
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
63 KB
Volume
15
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Pegylated interferon monotherapy of chro
✍ Fabrizio Fabrizi; Vivek Dixit; Piergiorgio Messa; Paul Martin πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 2 views

## Abstract The efficacy and safety of pegylated interferon monotherapy in patients with chronic renal failure and chronic hepatitis C remains unclear, although a number of small clinical trials have been published addressing this issue. A systematic review of the literature with a meta‐analysis of

Efficacy of interferon-based antiviral t
✍ FranΓ§ois D'Heygere; Christophe George; Hans Van Vlierberghe; Jochen Decaestecker πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 118 KB πŸ‘ 2 views

## Abstract The characteristics and response rate to pegylated interferon and ribavirin (PEG‐INF + RBV) of patients with chronic hepatitis C infected with genotype 5 are poorly documented. A meta‐analysis of two large phase III/IV prospective randomized clinical trials conducted in Belgium in patie

Impact of disease severity on outcome of
✍ Gregory T. Everson; John C. Hoefs; Leonard B. Seeff; Herbert L. Bonkovsky; Deepa πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 352 KB πŸ‘ 1 views

In patients with chronic hepatitis C, advanced fibrosis and cirrhosis are associated with lower rates of sustained virologic response (SVR) to interferon (IFN)-based therapy. In this study, we assessed virologic response to retreatment with peginterferon alfa-2a and ribavirin (RBV), as a function of